Summary:
A randomized, double-blind, placebo-controlled, multicenter trial with an enriched study design to assess the efficacy and safety of oxycodone/naloxone controlled-release tablets (oxn) compared to placebo in opioid-experienced subjects with moderate to severe pain due to chronic low back pain who require around-the-clock opioid therapy.
Qualified Participants Must:
• Be 18 years of age or older
•
Have documented low back pain for at least 3 months
•
Not have pain adequately treated prior to the screening visit with their stable incoming opioid analgesic medication(s)